BRIEF published on 05/19/2025 at 19:21, 1 year 5 months ago EB Development dépasse les 90 % du capital d'Eurobio Scientific Diagnostic In Vitro Réunion Financière Eurobio Scientific Développement EB 90 % Des Actions
PRESS RELEASE published on 05/19/2025 at 19:16, 1 year 5 months ago Eurobio Scientific : EB Development franchit à la hausse le seuil de 90% EB Development franchit à la hausse le seuil de 90% du capital d'Eurobio Scientific suite à une acquisition d'actions sur le marché. Prochain rendez-vous financier : Assemblée générale le 19 juin 2025 Franchissement De Seuil Assemblée Générale Diagnostic Médical Eurobio Scientific EB Development
PRESS RELEASE published on 05/19/2025 at 19:16, 1 year 5 months ago Eurobio Scientific: EB Development rises above 90% threshold Eurobio Scientific's shareholder EB Development surpasses 90% share capital threshold through market acquisitions. Financial meeting: Annual General Meeting on June 19, 2025 Share Capital Eurobio Scientific EB Development Financial Meeting 90% Threshold
BRIEF published on 04/29/2025 at 21:05, 1 year 6 months ago Mise à disposition du rapport financier annuel 2024 par Eurobio Scientific Diagnostic In Vitro Assemblée Générale Investisseurs Rapport Annuel 2024 Eurobio Scientific
BRIEF published on 04/29/2025 at 21:05, 1 year 6 months ago Availability of the 2024 annual financial report by Eurobio Scientific Investors In Vitro Diagnostics General Meeting Annual Report 2024 Eurobio Scientific
PRESS RELEASE published on 04/29/2025 at 21:00, 1 year 6 months ago Eurobio Scientific: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2024 Eurobio Scientific annonce la mise à disposition de son rapport financier annuel 2024 auprès du public et de l'AMF Assemblée Générale Investisseurs Rapport Financier Annuel Diagnostic Médical Eurobio Scientific
BRIEF published on 03/04/2025 at 20:08, 1 year 7 months ago Eurobio Scientific met fin à son contrat de liquidité Contrat De Liquidité TP ICAP Euronext Growth Diagnostic Médical Eurobio Scientific
BRIEF published on 03/04/2025 at 20:08, 1 year 7 months ago Eurobio Scientific terminates its liquidity contract Liquidity Contract TP ICAP Euronext Growth Medical Diagnosis Eurobio Scientific
PRESS RELEASE published on 03/04/2025 at 20:03, 1 year 7 months ago Eurobio Scientific : résiliation du contrat de liquidité Eurobio Scientific met fin au contrat de liquidité avec TP ICAP et communique sur ses moyens en compte. L'action est cotée sur Euronext Growth Paris Euronext Growth Paris Contrat De Liquidité Diagnostic Médical Fin Eurobio Scientific
BRIEF published on 01/15/2025 at 17:51, 1 year 9 months ago Eurobio Scientific : Publication du calendrier financier 2025 Calendrier Financier Bourse Diagnostic Médical Eurobio Scientific Résultats 2025
Published on 10/30/2026 at 23:35, 1 day 14 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 15 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 19 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 23 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/01/2026 at 10:35, 3 hours 57 minutes ago Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 9 hours 32 minutes ago 2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 21 hours 57 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 15 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 1 day 15 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 1 day 15 hours ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
